[Trimethoprim-oxolinic acid combination. In vitro interaction, bioavailability and clinical use].
D000328:Adult; D001682:Biological Availability; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004347:Drug Interactions; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010093:Oxolinic Acid / Q000378:metabolism* / Q000627:therapeutic use; D014295:Trimethoprim / Q000378:metabolism* / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D014295:Trimethoprim; D010093:Oxolinic Acid
Associazione trimethoprim-acido oxolinico. Interazione "in vitro", biodisponibilità e impiego clinico.